Bial

bial is an international pharmaceutical group with products available in more than 50 countries. being the largest portuguese pharmaceutical company, bial has a strong presence in the iberian peninsula as well as in countries in latin america and french or portuguese speaking african countries. the company headquarters are located in portugal. bial has also facilities in spain – a manufacturing installation and a r&d center -, italy, mozambique, panama, among other countries. bial is strongly committed to therapeutic innovation investing more than 20% of its turnover in r&d every year. bial has launched the first drug of portuguese patent, an anti-epileptic already available in the us and several european markets. the second pharmaceutical of its own research, for the treatment of the parkinson disease, is already in an advanced development process (phase iii of clinical development ). the company expects to introduce more new medicines to the market in the next years, specific